Michael V Rocco
Overview
Explore the profile of Michael V Rocco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
137
Citations
6909
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Upadhya B, Willard J, Lovato L, Rocco M, Lewis C, Oparil S, et al.
Circ Heart Fail
. 2021 Nov;
14(12):e008322.
PMID: 34823375
Background: In the SPRINT (Systolic Blood Pressure Intervention Trial), intensive BP treatment reduced acute decompensated heart failure (ADHF) events. Here, we report the effect on HF with preserved ejection fraction...
12.
Wright Jr J, Whelton P, Johnson K, Snyder J, Reboussin D, Cushman W, et al.
Hypertension
. 2021 Nov;
78(6):1701-1710.
PMID: 34757768
The SPRINT (Systolic Blood Pressure Intervention Trial) results have influenced clinical practice but have also generated discussion regarding the validity, generalizability, and importance of the findings. Following the SPRINT primary...
13.
Raimann J, Chan C, Daugirdas J, Depner T, Greene T, Kaysen G, et al.
Kidney Blood Press Res
. 2021 Oct;
46(6):768-776.
PMID: 34644706
Introduction: The Frequent Hemodialysis Network (FHN) Daily and Nocturnal trials aimed to compare the effects of hemodialysis (HD) given 6 versus 3 times per week. More frequent in-center HD significantly...
14.
Glasser S, Vitolins M, Rocco M, Still C, Cofield S, Haley W, et al.
Am J Hypertens
. 2021 Sep;
35(2):182-191.
PMID: 34528669
Background: Adherence to study medications is crucial to evaluating treatment effects in clinical trials. To assess whether in the SPRINT trial, adherence and cardiovascular outcomes are associated regardless of intervention...
15.
Lewis C, Fine L, Beddhu S, Cheung A, Cushman W, Cutler J, et al.
N Engl J Med
. 2021 May;
384(20):1921-1930.
PMID: 34010531
Background: In a previously reported randomized trial of standard and intensive systolic blood-pressure control, data on some outcome events had yet to be adjudicated and post-trial follow-up data had not...
16.
Upadhya B, Pajewski N, Rocco M, Hundley W, Aurigemma G, Hamilton C, et al.
Hypertension
. 2021 Mar;
77(5):1571-1580.
PMID: 33775127
[Figure: see text].
17.
Macedo E, Hemmila U, Sharma S, Claure-Del Granado R, Mzinganjira H, Burdmann E, et al.
PLoS Med
. 2021 Jan;
18(1):e1003408.
PMID: 33444372
Background: Acute kidney injury (AKI) is increasingly encountered in community settings and contributes to morbidity, mortality, and increased resource utilization worldwide. In low-resource settings, lack of awareness of and limited...
18.
Ng J, Smyth B, Marshall M, Kang A, Pinter J, Bassi A, et al.
Nephrol Dial Transplant
. 2020 Dec;
36(4):695-703.
PMID: 33367715
Background: Dialysate sodium (DNa) prescription policy differs between haemodialysis (HD) units, and the optimal DNa remains uncertain. We sought to summarize the evidence on the agreement between prescribed and delivered...
19.
Malhotra R, Katz R, Jotwani V, Agarwal A, Cohen D, Cushman W, et al.
Am J Kidney Dis
. 2020 Dec;
78(1):48-56.
PMID: 33333147
Rationale And Objective: Although low estimated glomerular filtration rate (eGFR) is associated with cardiovascular disease (CVD) events and mortality, the clinical significance of variability in eGFR over time is uncertain....
20.
Rocco M, Comeau M, Marion M, Freedman B, Hawfield A, Langefeld C
Hypertension
. 2020 Oct;
76(6):1717-1724.
PMID: 33100049
Intensive blood pressure control decreases the rate of cardiovascular events by >25% compared with standard blood pressure control. We sought to determine whether the decrease in cardiovascular events seen with...